ResearcherFirst Affiliated Hospital of Zhengzhou UniversityActive in the last 2 years

Xing Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7100-758X; OpenAlex author ID A5073426040. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcinoma. Co-author DOI 10.1186/s10020-024-01049-6 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yuyuan Zhang · 1 shared paper, 2025 · strength 0.22
- Paper Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcin… DOI 10.1186/s10020-024-01049-6 ↗
Peng Luo · 1 shared paper, 2025 · strength 0.22
- Paper Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcin… DOI 10.1186/s10020-024-01049-6 ↗
Libo Wang · 1 shared paper, 2025 · strength 0.22
- Paper Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcin… DOI 10.1186/s10020-024-01049-6 ↗
Xinwei Han · 1 shared paper, 2025 · strength 0.22
- Paper Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcin… DOI 10.1186/s10020-024-01049-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.